Literature DB >> 11788600

Consequences of mevalonate depletion. Differential transcriptional, translational, and post-translational up-regulation of Ras, Rap1a, RhoA, AND RhoB.

Sarah A Holstein1, Christine L Wohlford-Lenane, Raymond J Hohl.   

Abstract

Ras-related proteins are small GTPases that are post-translationally modified with mevalonate-derived isoprenoids. Although the effects of inhibition of isoprenylation on protein function have been examined, the consequences of depletion of isoprenoid pools on regulation of expression of isoprenylated proteins have yet to be investigated. In these studies we have shown that depletion of mevalonate results in increased total levels of Ras, Rap1a, RhoA, and RhoB in K562 cells. Cycloheximide and [(35)S]methionine pulse/pulse-chase experiments reveal that mevalonate depletion increases the de novo synthesis of Ras and RhoA and decreases the degradation of existing Ras and RhoA protein. Pretreatment with actinomycin D completely prevents the induced up-regulation of RhoB and only partially prevents the up-regulation of Ras, Rap1a, and RhoA. Although depletion of mevalonate does not alter steady state levels of Ras mRNA, there is an increase in RhoB mRNA. Our results are the first to demonstrate that mevalonate depletion induces up-regulation of Ras and Ras-related proteins by discrete mechanisms that include modulation of transcriptional, translational, and post-translational processes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788600     DOI: 10.1074/jbc.M111369200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Pleiotropic effects of a schweinfurthin on isoprenoid homeostasis.

Authors:  Sarah A Holstein; Craig H Kuder; Huaxiang Tong; Raymond J Hohl
Journal:  Lipids       Date:  2011-06-02       Impact factor: 1.880

2.  The genetic basis of cellular morphogenesis in the filamentous fungus Neurospora crassa.

Authors:  Stephan Seiler; Michael Plamann
Journal:  Mol Biol Cell       Date:  2003-09-05       Impact factor: 4.138

3.  In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution.

Authors:  Staci L Haney; Yashpal S Chhonker; Michelle L Varney; Geoffrey Talmon; Lynette M Smith; Daryl J Murry; Sarah A Holstein
Journal:  J Pharmacol Exp Ther       Date:  2019-08-16       Impact factor: 4.030

4.  Effects of zoledronic acid and docetaxel on small GTP-binding proteins in prostate cancer.

Authors:  Rachel M Jones; Claire Morgan; Gianfilippo Bertelli
Journal:  Tumour Biol       Date:  2015-01-29

5.  Upstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids.

Authors:  Isao Eto
Journal:  Cancer Cell Int       Date:  2010-02-19       Impact factor: 5.722

Review 6.  Isoprenoids: remarkable diversity of form and function.

Authors:  Sarah A Holstein; Raymond J Hohl
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

7.  Isoprenoid alcohols restore protein isoprenylation in a time-dependent manner independent of protein synthesis.

Authors:  Susan E Ownby; Raymond J Hohl
Journal:  Lipids       Date:  2003-07       Impact factor: 1.880

8.  Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.

Authors:  Stephanie J Turner; Shunhui Zhuang; Tong Zhang; Gerry R Boss; Renate B Pilz
Journal:  Biochem Pharmacol       Date:  2007-09-01       Impact factor: 5.858

9.  Quantitative determination of geranyl diphosphate levels in cultured human cells.

Authors:  Sarah A Holstein; Huaxiang Tong; Craig H Kuder; Raymond J Hohl
Journal:  Lipids       Date:  2009-10-24       Impact factor: 1.880

10.  A chemical biology screen reveals a role for Rab21-mediated control of actomyosin contractility in fibroblast-driven cancer invasion.

Authors:  S Hooper; C Gaggioli; E Sahai
Journal:  Br J Cancer       Date:  2009-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.